Edition:
United Kingdom

Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

3.62USD
9:02pm BST
Change (% chg)

$-0.04 (-1.09%)
Prev Close
$3.66
Open
$3.68
Day's High
$3.70
Day's Low
$3.59
Volume
28,232
Avg. Vol
46,674
52-wk High
$6.88
52-wk Low
$2.33

Latest Key Developments (Source: Significant Developments)

James Roumell Reports 4.1 Pct Stake In Enzo Biochem
Tuesday, 26 Mar 2019 

March 26 (Reuters) - Enzo Biochem Inc ::JAMES ROUMELL REPORTS 4.1 PERCENT SHARE STAKE IN ENZO BIOCHEM INC AS OF MARCH 22 - SEC FILING.JAMES C. ROUMELL - AS OF MARCH 22, DECIDED TO SEND LETTER TO ENZO BIOCHEM BOARD TO ASK IT REVIEW STRATEGIC OPTIONS.JAMES C. ROUMELL - SENT A LETTER, DATED MARCH 26, 2019, TO ENZO BOARD OF DIRECTORS.JAMES ROUMELL SAYS ACQUIRED ENZO BIOCHEM SHARES FOR INVESTMENT PURPOSES, BASED ON BELIEF THAT CO'S STOCK IS UNDERVALUED.JAMES ROUMELL SAYS MAY ALSO ENTER INTO DISCUSSIONS WITH THIRD PARTIES AND OTHER STOCKHOLDERS OF ENZO BIOCHEM INC.  Full Article

Enzo Biochem Enters Settlement Agreement With Roche
Monday, 11 Feb 2019 

Feb 11 (Reuters) - Enzo Biochem Inc ::ENZO BIOCHEM INC - CO ALONG WITH ITS UNIT ENTERED INTO A SETTLEMENT AGREEMENT AS OF FEBRUARY 5, 2019 WITH ROCHE - SEC FILING.ENZO BIOCHEM INC - ROCHE HAS AGREED TO PAY $21 MILLION IN SETTLEMENT PURSUANT TO AGREEMENT.  Full Article

Enzo Biochem Q1 Loss Per Share $0.13
Monday, 10 Dec 2018 

Dec 10 (Reuters) - Enzo Biochem Inc ::ENZO BIOCHEM REPORTS FISCAL 2019 FIRST QUARTER RESULTS.Q1 REVENUE $21.3 MILLION VERSUS $26.9 MILLION.Q1 NON-GAAP LOSS PER SHARE $0.13.TOTAL CASH AND CASH EQUIVALENTS AT OCTOBER 31, 2018 WERE $52.8 MILLION COMPARED TO $60.0 MILLION AT JULY 31, 2018.  Full Article

Enzo Biochem Q3 Non-Gaap Loss Per Share $0.06
Monday, 11 Jun 2018 

June 11 (Reuters) - Enzo Biochem Inc ::ENZO BIOCHEM REPORTS THIRD QUARTER RESULTS.Q3 NON-GAAP LOSS PER SHARE $0.06.TOTAL REVENUES IN QUARTER AMOUNTED TO $25.6 MILLION OR 5% LOWER THAN PRIOR YEAR.TOTAL CASH AND CASH EQUIVALENTS AT APRIL 30, 2018 WERE $62.6 MILLION COMPARED TO $64.2 MILLION AT JULY 31, 2017.  Full Article

Enzo Biochem Reports Q2 Adjusted Loss Per Share $0.04
Monday, 12 Mar 2018 

March 12 (Reuters) - Enzo Biochem Inc ::ENZO BIOCHEM REPORTS SECOND QUARTER AND FIRST HALF RESULTS.Q2 ADJUSTED LOSS PER SHARE $0.04.Q2 REVENUE ROSE 3 PERCENT TO $27 MILLION.QTRLY LOSS PER SHARE $0.02.  Full Article

Enzo Biochem Q1 Non-GAAP Loss Per Share $0.01
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Enzo Biochem Inc ::ENZO BIOCHEM REPORTS IMPROVED FIRST QUARTER RESULTS.Q1 NON-GAAP LOSS PER SHARE $0.01.Q1 REVENUE $27.7 MILLION VERSUS $26.3 MILLION.  Full Article

‍Enzo Biochem announces NYS department of health's approval of a new women's health infectious disease panel​
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Enzo Biochem Inc ::‍Enzo Biochem announces NYS department of health's approval of a new women's health infectious disease panel​.  Full Article

BRIEF-Enzo Biochem Q4 non-gaap net income of $0.00 per share (Sept 27)
Thursday, 28 Sep 2017 

Corrects headline and third bullet to Q4 non-gaap net income of $0.00/share from non-gaap loss of $0.04/share:Enzo Biochem reports increase in revenues and profitable fourth quarter.Q4 revenue $28.2 million versus $26.6 million.Q4 non-gaap net income per share $0.00.  Full Article

Enzo Biochem Q4 non-gaap loss per share $0.04
Wednesday, 27 Sep 2017 

Sept 27 (Reuters) - Enzo Biochem Inc :Enzo Biochem reports increase in revenues and profitable fourth quarter.Q4 revenue $28.2 million versus $26.6 million.Q4 non-gaap loss per share $0.04.  Full Article

Enzo Biochem files for mixed shelf of up to $150 million ‍​
Friday, 1 Sep 2017 

Sept 1 (Reuters) - Enzo Biochem Inc :Files for mixed shelf of up to $150 million - SEC filing ‍​.  Full Article

BRIEF-Enzo Biochem Enters Settlement Agreement With Roche

* ENZO BIOCHEM INC - CO ALONG WITH ITS UNIT ENTERED INTO A SETTLEMENT AGREEMENT AS OF FEBRUARY 5, 2019 WITH ROCHE - SEC FILING